by Dale Harrison | Dec 1, 2022 | Publications
Cell Bio, a joint meeting of the American Society for Cell Biology (ASCB) and European Molecular Biology Organization (EMBO), in Washington, D.C., on Dec. 3-7, 2022. AuthorsDavid J. Elzi, Reggie Jacob, and Vivienne I. Rebel Introduction Cobalamin (Vitamin B12) is an...
by Dale Harrison | Dec 1, 2022 | Events
December 1, 2022 bioAffinity will attend the NAVREF Industry Consortium Q1 Meeting on December 5-7, 2022 in Miami Florida. About The IPC Meeting for FY23 Q1 This day-and-a-half meeting is designed to be an opportunity to launch our efforts in 2023. ...
by Dale Harrison | Dec 1, 2022 | Events
December 1, 2022 bioAffinity Technologies will present at at Cell Bio during the American Society for Cell Biology (ASCB) and European Molecular Biology Organization (EMBO) Conference bioAffinity reports on a potential therapeutic approach that kills cancer cells...
by Dale Harrison | Dec 1, 2022 | Press Releases
bioAffinity reports on a potential therapeutic approach that kills cancer cells without harm to normal cells SAN ANTONIO, TX – Dec. 1, 2022 – bioAffinity Technologies, Inc. (NASDAQ: BIAF; BIAFW), a biotechnology company addressing the need for noninvasive diagnosis of...
by Dale Harrison | Nov 29, 2022 | Articles, News
After going public, SA company charts next course NOVEMBER 29, 2022 As published in the San Antonio Business Journal By: W. Scott Bailey – Senior Reporter, San Antonio Business Journal Fresh off of filing its first earnings report as a publicly traded company, San...
